Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Thickeners and Stabilizers
Taste Masking
Direct Compression
Solubilizers
Emulsifying Agents
Granulation
Lubricants & Glidants
Coating Systems & Additives
Parenteral
Topical
Rheology Modifiers
Chewable & Orodispersible Aids
API Stability Enhancers
Film Formers & Plasticizers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Clindamycin Palmitate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clindamycin Palmitate manufacturer or Clindamycin Palmitate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clindamycin Palmitate manufacturer or Clindamycin Palmitate supplier.
PharmaCompass also assists you with knowing the Clindamycin Palmitate API Price utilized in the formulation of products. Clindamycin Palmitate API Price is not always fixed or binding as the Clindamycin Palmitate Price is obtained through a variety of data sources. The Clindamycin Palmitate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Clindamycin Palmitate HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clindamycin Palmitate HCl, including repackagers and relabelers. The FDA regulates Clindamycin Palmitate HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clindamycin Palmitate HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clindamycin Palmitate HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clindamycin Palmitate HCl supplier is an individual or a company that provides Clindamycin Palmitate HCl active pharmaceutical ingredient (API) or Clindamycin Palmitate HCl finished formulations upon request. The Clindamycin Palmitate HCl suppliers may include Clindamycin Palmitate HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Clindamycin Palmitate HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clindamycin Palmitate HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Clindamycin Palmitate HCl active pharmaceutical ingredient (API) in detail. Different forms of Clindamycin Palmitate HCl DMFs exist exist since differing nations have different regulations, such as Clindamycin Palmitate HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Clindamycin Palmitate HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Clindamycin Palmitate HCl USDMF includes data on Clindamycin Palmitate HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clindamycin Palmitate HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Clindamycin Palmitate HCl suppliers with USDMF on PharmaCompass.
A Clindamycin Palmitate HCl written confirmation (Clindamycin Palmitate HCl WC) is an official document issued by a regulatory agency to a Clindamycin Palmitate HCl manufacturer, verifying that the manufacturing facility of a Clindamycin Palmitate HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Clindamycin Palmitate HCl APIs or Clindamycin Palmitate HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Clindamycin Palmitate HCl WC (written confirmation) as part of the regulatory process.
click here to find a list of Clindamycin Palmitate HCl suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clindamycin Palmitate HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Clindamycin Palmitate HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Clindamycin Palmitate HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Clindamycin Palmitate HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clindamycin Palmitate HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Clindamycin Palmitate HCl suppliers with NDC on PharmaCompass.
Clindamycin Palmitate HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Clindamycin Palmitate HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clindamycin Palmitate HCl GMP manufacturer or Clindamycin Palmitate HCl GMP API supplier for your needs.
A Clindamycin Palmitate HCl CoA (Certificate of Analysis) is a formal document that attests to Clindamycin Palmitate HCl's compliance with Clindamycin Palmitate HCl specifications and serves as a tool for batch-level quality control.
Clindamycin Palmitate HCl CoA mostly includes findings from lab analyses of a specific batch. For each Clindamycin Palmitate HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Clindamycin Palmitate HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Clindamycin Palmitate HCl EP), Clindamycin Palmitate HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clindamycin Palmitate HCl USP).
